StockData
TG Therapeutics, Inc. logo

TG Therapeutics, Inc. (TGTX) stock

TGTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3010% above fair value
$64.88−1.24 (-1.88%)

Close on Nov 19, 2026Market cap $9.93BP/E 23.7Yield –

TG Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

TG Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $799.54M, up 76.1% year over year. For fiscal 2025 it was $616.29M, up 87.3% from the year before. The highest annual figure on record is $616.29M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$616.29M+87.3%
FY2024Dec 31, 2024$329.00M+40.8%
FY2023Dec 31, 2023$233.66M+8290.0%
FY2022Dec 31, 2022$2.79M-58.4%
FY2021Dec 31, 2021$6.69M+4300.7%
FY2020Dec 31, 2020$152.00K0.0%
FY2019Dec 31, 2019$152.00K0.0%
FY2018Dec 31, 2018$152.00K0.0%
FY2017Dec 31, 2017$152.00K0.0%
FY2016Dec 31, 2016$152.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$240.34M+70.3%
Q1 FY2026Mar 31, 2026$204.92M+69.6%
Q4 FY2025Dec 31, 2025$192.57M+78.0%
Q3 FY2025Sep 30, 2025$161.71M+92.8%
Q2 FY2025Jun 30, 2025$141.15M+92.1%
Q1 FY2025Mar 31, 2025$120.86M+90.4%
Q4 FY2024Dec 31, 2024$108.19M+146.0%
Q3 FY2024Sep 30, 2024$83.88M-49.4%
Q2 FY2024Jun 30, 2024$73.47M+357.0%
Q1 FY2024Mar 31, 2024$63.47M+713.5%
Q4 FY2023Dec 31, 2023$43.97M+54863.8%
Q3 FY2023Sep 30, 2023$165.82M+176298.9%
Q2 FY2023Jun 30, 2023$16.07M+2606.1%
Q1 FY2023Mar 31, 2023$7.80M+287.1%
Q4 FY2022Dec 31, 2022$80.00K-96.6%
Q3 FY2022Sep 30, 2022$94.00K-95.4%
Q2 FY2022Jun 30, 2022$594.00K-61.6%
Q1 FY2022Mar 31, 2022$2.02M+154.2%
Q4 FY2021Dec 31, 2021$2.32M+6007.9%
Q3 FY2021Sep 30, 2021$2.03M+5242.1%
Q2 FY2021Jun 30, 2021$1.55M+3965.8%
Q1 FY2021Mar 31, 2021$793.00K+1986.8%
Q4 FY2020Dec 31, 2020$38.00K0.0%
Q3 FY2020Sep 30, 2020$38.00K0.0%
Q2 FY2020Jun 30, 2020$38.00K0.0%
Q1 FY2020Mar 31, 2020$38.00K0.0%
Q4 FY2019Dec 31, 2019$38.00K0.0%
Q3 FY2019Sep 30, 2019$38.00K0.0%
Q2 FY2019Jun 30, 2019$38.00K0.0%
Q1 FY2019Mar 31, 2019$38.00K0.0%
Q4 FY2018Dec 31, 2018$38.00K0.0%
Q3 FY2018Sep 30, 2018$38.00K0.0%
Q2 FY2018Jun 30, 2018$38.00K0.0%
Q1 FY2018Mar 31, 2018$38.00K–
Q4 FY2017Dec 31, 2017$38.00K–
Q3 FY2017Sep 30, 2017$38.00K–
Q2 FY2017Jun 30, 2017$38.00K–

More TG Therapeutics figures

See a number that looks wrong?